Approaches for Covid-19 infection control in the workplaces

Chemoprophylatic. Ayurvedic, Homeopathic and Unani approaches for COVID-19 prophylaxis

There are no specific therapies approved by the U.S. FDA for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 COVID-19. Several agents are under clinical trial and the use of pharmacological agents are based on in vitro activity against SARS-CoV-2 or related viruses. While the efficacy of drug therapy is yet to be established, we need ...

Predisposing risk factors for COVID-19 infection: a case-control study

Background: The ongoing epidemics of coronavirus disease 2019 (COVID-19) have caused serious concerns in terms of public health. Literature that focuses on the risk factors of this issue is limited especially in developing countries. This study aimed to determine the predictors of COVID-19 infection in the west region of Iran. Methods: This case-control study was conducted from February to Apr...

Comorbidity Affecting the Severity of COVID-19 Infection in Iraq

Aims: COIVD-19 Patients suffering from other diseases such as diabetic mellitus, asthma and obstructive pulmonary disease have increased morbidity and mortality rates resulting in more hospitalization and intensive therapy unit admissions. The study aimed to characterise and investigate the clinical pattern and the severity of symptoms in COVID-19 patients and to study its relationship with the...

COVID-19 pandemic: Challenges and approaches in blood transfusions

One of the goals of the Iranian Blood Transfusion Organization is to provide adequate healthy blood and reduce the risk of various viral and bacterial transmission infections. With the removal of alternative blood donation, all blood units and blood products are provided through voluntary blood donation in Iran. The Blood Transfusion Organization screens the donated blood according to standard ...

Nutrition and Infection with COVID-19

The correlation between H. pylori infection and COVID-19

SARS CoV-2 and H. pylori are pathogens associated with the most common viral and bacterial infections globally. The co-infection of pathogenic bacteria and SARS CoV-2 represented  a true health challenge. The current study aimed to estimate the incidence of H. pylori in patients with COVID-19. For this purpose, 130 patients with RT-PCR confirmed SARS CoV-2 infection as well as 130 apparently he...